Kim Chang-Hoon, Hong Ji-Youn, Shin SeungIl, Shin Seung-Yun, Chung Jong-Hyuk, Thoma Daniel S, Lim Hyun-Chang
Department of Dentistry, Graduate School, Kyung Hee University, Seoul, Korea.
Department of Periodontology, Periodontal Implant Clinical Research Institute, Kyung Hee University, College of Dentistry, Kyung Hee University Medical Center, Seoul, Korea.
Clin Implant Dent Relat Res. 2025 Feb;27(1):e13411. doi: 10.1111/cid.13411. Epub 2024 Oct 27.
The objective of this study is to investigate the effect of collagen matrix with polydeoxyribonucleotide (PDRN) at two concentrations on keratinized tissue (KT) regeneration for buccally positioned implants in canines.
Four implants were placed in the edentulous mandible of five dogs simultaneously with KT removal. The implants were positioned buccally with respect to the ridge crest. After 2 months, KT augmentation was performed applying the following treatment modalities:(1) free gingival graft (FGG), (2) xenogeneic collagen matrix (XCM), (3) XCM loaded with 2 mg/mL PDRN (PDRN2), and (4) XCM loaded with 4 mg/mL PDRN (PDRN4). All animals were sacrificed 3 months later. Outcomes included clinical (KT height) and histomorphometric measurements (KT height/length, level of the mucosa, mucosal thickness, supracrestal soft tissue height).
Clinical and histomorphometric KT formation at 3 months was greatest in groups with FGG (4.70 ± 1.00/3.94 ± 0.93 mm) and PDRN2 (4.85 ± 1.43/3.95 ± 0.87 mm). Group PDRN2 (1.87 ± 1.50 mm) showed a higher marginal mucosal level with respect to the implant platform compared to other groups (range: 0.57 ± 0.97-0.69 ± 1.14 mm). All groups presented a soft tissue thickness of < 2 mm on the buccal aspect of the implants.
Based on the limitations of this pilot preclinical study, XCM with 2 mg/mL of PDRN demonstrated a potential for KT augmentation.
本研究的目的是调查两种浓度的聚脱氧核糖核苷酸(PDRN)胶原蛋白基质对犬颊侧种植体角化组织(KT)再生的影响。
在五只犬的无牙下颌骨中同时植入四颗种植体并切除KT。种植体相对于牙槽嵴顶位于颊侧。2个月后,采用以下治疗方式进行KT增量:(1)游离龈瓣移植(FGG),(2)异种胶原蛋白基质(XCM),(3)负载2mg/mL PDRN的XCM(PDRN2),以及(4)负载4mg/mL PDRN的XCM(PDRN4)。3个月后处死所有动物。结果包括临床指标(KT高度)和组织形态计量学测量指标(KT高度/长度、黏膜水平、黏膜厚度、龈上软组织高度)。
3个月时,FGG组(4.70±1.00/3.94±0.93mm)和PDRN2组(4.85±1.43/3.95±0.87mm)的临床和组织形态计量学KT形成情况最佳。与其他组相比,PDRN2组(1.87±1.50mm)相对于种植体平台的边缘黏膜水平更高(范围:0.57±0.97 - 0.69±1.14mm)。所有组在种植体颊侧的软组织厚度均<2mm。
基于这项初步临床前研究的局限性,含2mg/mL PDRN的XCM显示出KT增量的潜力。